Navigation Links
Studies in Mice May Offer Clues to Cleft Lip
Date:12/1/2011

THURSDAY, Dec. 1 (HealthDay News) -- The genetic repair of cleft lips in mice embryos could eventually lead to new ways to treat and prevent the birth defect in humans, U.S. researchers report.

The scientists pinpointed the role of genes for specific proteins that coordinate cellular signaling behaviors that play a major role in the development of cleft lip and palate. Working with specially engineered mice, they also reported that altering one type of molecule within a specific signaling pathway can correct cleft lip and palate.

The study was published recently in the journal Developmental Cell.

This is the first time that anyone has corrected this defect in embryos, according to study author Dr. Licia Selleri, an associate professor of cell and developmental biology at Weill Cornell Medical College in New York City.

"This is a very provocative result because it opens a completely new avenue of strategies for tissue repair," she said in a medical college news release.

While the findings hold promise, experts note that research involving animals frequently fails to lead to benefits for humans.

Children born with cleft lip and cleft palate, which are among the most common birth defects, often require multiple surgeries, speech therapy and orthodontics because of the disfigurement.

More information

The Nemours Foundation has more about cleft lip and palate.

-- Robert Preidt

SOURCE: Weill Cornell Medical College, news release, Nov. 28, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Studies of patients with cirrhosis uncover limitations in liver cancer screening
2. Surgeon studies with world-renowned oncoplastic pioneer
3. Studies explore new approaches to treating pain
4. New studies show progress, value in vaccination against deadly pneumonia
5. UH Rainbow Babies & Childrens Hospital begins studies on vitamin D to prevent heart disease
6. Studies Suggest Link Between Smog, Joint Disease
7. Gene therapy shows promise as hemophilia treatment in animal studies
8. MU studies link depression and breast cancer outcomes
9. CHEST 2011: Embargoed studies highlight new lung cancer and COPD research
10. European studies on risks of hepatocellular carcinoma
11. Trio of studies support use of PET/CT scans as prostate cancer staging tool
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Studies in Mice May Offer Clues to Cleft Lip
(Date:4/22/2017)... ... April 22, 2017 , ... Brian Emmer brings more than ... and Business Development at OAKWORKS, Inc. Mr. Emmer is responsible for the ... planning for the company. Recognized industry-wide as a healthcare innovator, Emmer has ...
(Date:4/21/2017)... ... ... at Palm Beach Face is proud to announce that their practice founder, Michael Schwartz ... place on April 23rd, the London Marathon has a long tradition of raising funds for ... EMPOWER, raising money for the international charity, Smile Train. , Started in 1981 ...
(Date:4/21/2017)... ... 21, 2017 , ... Brady (NYSE:BRC), a global leader in industrial ... B-7569 vinyl label materials received certification for the BS5609 British Marine Standard. ... intact and legible, for use on chemical drums shipped by sea. , ...
(Date:4/21/2017)... , ... April 21, 2017 , ... The Patient Advocacy ... Health System, with the 2017 Ruth Ravich Patient Advocacy Award in recognition ... advocates. DeVaro was honored with the award at The Beryl Institute’s annual Patient ...
(Date:4/21/2017)... ... April 21, 2017 , ... The American Medical Student Association ... and Recovery Education, from April 24 to April 28, 2017, dedicated to increasing ... , The mission of AWARE is to instill a compassionate, total health approach ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... DALLAS , April 19, 2017  Vanderbilt University ... first patients in Nashville , Tennesse ... Lower Esophageal Sphincter Stimulation for GERD (LESS GERD) trial. ... to provide long-term reflux control by restoring normal function ... nearly 65 million people in the United ...
(Date:4/19/2017)... HANOVER, N.J. , April 19, 2017 /PRNewswire/ ... conducted by the National Heart, Lung, and Blood ... (NIH) demonstrating that 58% of patients with treatment-naïve ... six months when treated with eltrombopag at the ... 1 . The study evaluated three sequential treatment ...
(Date:4/18/2017)... Research and Markets has announced the addition ... their offering. ... devices market to grow at a CAGR of 6.35% during the ... 2017-2021, has been prepared based on an in-depth market analysis with ... its growth prospects over the coming years. The report also includes ...
Breaking Medicine Technology: